Glucagon (medication)

Property	Value
rdf:type	World Health Organization essential medicine owl:NamedIndividual Signaling peptide/protein receptor modulator Eli Lilly and Company brand Drug acting on the cardiovascular system
rdfs:label	Glucagon (medication)
owl:sameAs	dbr:Glucagon_(medication)
prov:wasDerivedFrom	http://en.wikipedia.org/wiki/Category:Drugs_acting_on_the_cardiovascular_system http://en.wikipedia.org/wiki/Pheochromocytoma http://en.wikipedia.org/wiki/Signaling_peptide_receptor http://en.wikipedia.org/wiki/Category:Eli_Lilly_and_Company_brands http://en.wikipedia.org/wiki/Category:World_Health_Organization_essential_medicines http://en.wikipedia.org/wiki/List_of_signaling_peptide/protein_receptor_modulators http://en.wikipedia.org/wiki/Glucose-elevating_agent
skos:prefLabel	Glucagon (medication)
skos:altLabel	medication Glucagon glucagon injectable glucagon
clgo:alternativeName	Glucagen, Baqsimi, Gvoke, others
clgo:casNumber	16941-32-5
clgo:chEBI	5391
clgo:chEMBL	266481
clgo:drugbank	DB00040
clgo:fdaUniiCode	76LA80IG2G
clgo:kegg	C01501 D00116
clgo:license	Glucagon
clgo:medlinePlus	a682480
clgo:pubchem	16132283
is clgo:treatment of	Hypoglycemia

About: clgr:Glucagon_(medication)